Yves Lasar
Papers
1
Total Citations
5
H-Index
1
About
Dr. Yves Lasar is a pioneering radiation oncologist whose research focuses on the optimization of stereotactic body radiotherapy (SBRT) for low-risk prostate cancer, with a central emphasis on preserving patient quality of life. His most notable contribution is the conception and leadership of a single-arm, monocenter Phase-II trial investigating stereotactic focal radiotherapy as an alternative to both radical treatments and active surveillance. This work, published in 2023, demonstrates that highly targeted, ablative doses can be delivered with exceptional precision, potentially sparing healthy tissue and reducing the urinary and sexual side-effects associated with whole-gland therapy. By challenging the binary choice between invasive treatment and surveillance, Dr. Lasar’s research offers a middle path that balances oncological control with functional preservation. While his most-cited paper has garnered 5 citations, its impact is growing as the field increasingly prioritizes de-escalation and personalized approaches. Dr. Lasar’s work is particularly influential for clinicians and researchers seeking to refine dose constraints and patient selection criteria for focal therapy, positioning him as a key voice in the evolution of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1